Cite

HARVARD Citation

    Ogawa, H. et al. (2023). Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia. Cancer science. 114 (2), pp. 596-605. [Online]. 
  
Back to record